U.S. market Closed. Opens in 55 minutes

MRTX | Mirati Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
Revenue12.44M72.09M13.40M3.33M12.93MN/AN/AN/AN/AN/A2.01K3.03M2.39M2.88M24.24M15.65M13.75M5.76M7.68M7.71M
Cost of Revenue600.00K508.59M299.35M182.87M93.87M58.09M68.49MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit11.84M-436.50M-285.95M-179.53M-80.95M-58.09M-68.49MN/AN/AN/A2.01K3.03M2.39M2.88M24.24M15.65M13.75M5.76M7.68M7.71M
Operating Expenses771.42M645.27M382.76M225.44M115.55M71.53M83.78M64.71M38.77M30.94M20.55M12.81M17.10M25.45M33.03M38.10M16.98M19.12M16.19M11.83M
Selling, General & Admin239.80M136.68M83.41M42.57M21.68M13.45M15.29M15.76M12.70M11.14M5.41M4.20M6.21M5.06M4.55M4.96M4.28M4.20M3.87M2.74M
Research & Development531.63M508.59M299.35M182.87M93.87M58.09M68.49M48.96M26.07M19.80M15.14M8.47M10.87M20.01M29.33M33.13M17.81M14.88M12.28M8.10M
Other Operating Expenses19.23M-5.30M11.43M8.85M4.21M1.10M661.00K170.00K-4.59M1.02M0138.10K19.00K377.23K-848.81K17.17K-5.11M41.58K45.52K989.04K
Operating Income-759.59M-573.18M-369.36M-222.10M-102.63M-71.53M-83.78M-64.71M-39.10M-31.97M-20.55M-9.78M-14.71M-22.56M-8.80M-22.45M-3.23M-13.37M-8.51M-4.12M
Other Expenses / Income19.23M-5.30M11.43M8.85M4.21M1.10M661.00K170.00K-4.93M-21.91M177.94KN/A24.00K162.35K1.30M210.04K2.06M199.94K-581.70KN/A
Before Tax Income-740.36M-578.49M-357.94M-213.26M-98.42M-70.43M-83.12M-64.54M-43.70M-52.88M-20.32MN/A-14.68M-22.40M-7.49M-22.24M-1.17M-13.17M-9.09M-4.12M
Income Tax Expenses508.00K3.30M-511.00K-659.00K4.21M-130.00K-155.00K-249.00K121.00K-23.00K39.20K-256.61K4.00K127.97K-114.22K-3.10M5.27M-763.25K56.71K99.66K
Net Income-740.87M-581.78M-357.43M-212.60M-98.42M-70.48M-83.14M-64.51M-43.68M-52.87M-20.36M-9.53M-14.69M-22.53M-7.38M-22.24M-6.44M-13.17M-9.15M-4.22M
Interest ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/A203.00K31.16K27.42K31.00K20.05K13.15KN/A26.29K16.90KN/AN/A
Basic Shares Outstanding56.23M51.88M44.99M37.47M30.90M25.29M19.79M16.90M13.48M11.06M9.96M6.36M808.37K749.84K733.65K714.82K567.15K434.70K379.90K330.45K
Diluted Shares Outstanding56.23M51.88M44.99M37.47M30.90M25.29M19.79M16.90M13.48M11.06M9.96M6.36M808.37K749.84K733.65K714.82K567.15K434.70K379.90K330.45K
EBITDA-756.66M-571.40M-368.72M-222.10M-102.63M-71.53M-83.78M-64.71M2.01M-31.97M-20.38M-9.59M-13.95M-21.43M-6.37M-20.97M-1.95M-12.27M-7.23M-3.30M
EBITDA Margin-6,084.43%-792.60%-2,752.07%-6,659.79%-793.96%0.00%0.00%0.00%0.00%0.00%-1,013,483.06%-316.79%-584.05%-743.01%-26.29%-133.98%-14.15%-213.05%-94.18%-42.74%
EBIT-740.36M-578.49M-357.94M-213.26M-94.21M-70.61M-83.30M-64.76M-43.56M-52.69M-20.29M-9.76M-14.65M-22.38M-7.48M-25.34M-1.14M-13.91M-9.09M-4.12M
EBIT Margin-5,953.35%-802.43%-2,671.57%-6,394.48%-728.83%0.00%0.00%0.00%0.00%0.00%-1,009,200.04%-322.15%-613.48%-775.99%-30.86%-161.88%-8.32%-241.60%-118.34%-53.46%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙